0000885590-14-000034.txt : 20140430 0000885590-14-000034.hdr.sgml : 20140430 20140430163447 ACCESSION NUMBER: 0000885590-14-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140420 FILED AS OF DATE: 20140430 DATE AS OF CHANGE: 20140430 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kornwasser Laizer CENTRAL INDEX KEY: 0001387813 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 14799392 MAIL ADDRESS: STREET 1: 100 PARSONS POND DRIVE CITY: FRANKLIN LAKES STATE: NJ ZIP: 07417 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2014-04-20 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001387813 Kornwasser Laizer 400 SOMERSET CORPORATE BLVD BRIDGEWATER NJ 08807 0 1 0 0 EVP, Company Group Chairman Common Stock, no par value 2014-04-20 4 A 0 5017 0 A 58599 D Common Stock, no par value 2014-04-28 4 F 0 346 122.05 D 58253 D Common Stock, no par value 2014-04-28 4 M 0 45000 A 103253 D Common Stock, no par value 2014-04-28 4 F 0 23333 122.05 D 79920 D Restricted Share Units 2014-04-28 4 M 0 45000 A Common Stock 45000 45000 D Represents Restricted Share Units received under an Employee Share Matching Program ("Matching RSUs") in connection with the officer's purchase of Company common stock under a 10b5-1 trading plan. Each Matching RSU represents a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc. 1/3 of the Matching RSUs will vest each on the first, second and third anniversary of the date of grant subject to continued employment and retention of the corresponding purchased shares. This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Matching Restricted Share Units. This represents the number of units vested on the performance-based RSUs ("PSUs") that were previously reported on the original Form 4. The initial grant was reported to vest based on total shareholder return (TSR) between a price of $63.86 starting on February 1, 2013 and the average stock price for the 20 trading days starting on each measurement dates: 25% on November 1, 2015, 50% on February 1, 2016 and 25% on May 1, 2016. Unit vesting is contingent on TSR performance between 10% and 30% into between one and three shares of common stock, respectively, with early vesting possible at higher TSR levels. The PSU award may still payout grant value. This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Performance Share Units. by: Nicholas Zanoni for Laizer Kornwasser 2014-04-30